Out-of-Pocket Expenses for Long-Acting Reversible Contraceptives
Overview
This report examines the out-of-pocket expenses incurred by individuals with employer-sponsored insurance for long-acting reversible contraceptives (LARC), specifically intrauterine devices (IUDs) and contraceptive implants. Despite the ACA's mandate for cost-free contraceptive coverage, many users still face unexpected costs.
Background
The Affordable Care Act (ACA) requires that contraceptives be provided without cost-sharing, yet many privately insured individuals continue to experience out-of-pocket expenses for LARC. Understanding these costs is crucial for addressing barriers to contraceptive access and ensuring compliance with ACA provisions. This study utilizes a comprehensive claims database to analyze the financial burden on women aged 15-49.
Data Highlights
Type of Contraceptive
Insertion Encounters
IUD
98,916
Implant
30,259
Key Findings
Out-of-pocket costs for LARC insertion persist despite ACA mandates.
98,916 IUD and 30,259 implant insertion encounters were analyzed.
Many privately insured individuals face unexpected expenses for LARC services.
The study highlights ongoing implementation issues regarding contraceptive coverage.
Access to immediate postpartum or postabortion LARC remains challenging.
Clinical Implications
Healthcare providers should be aware of the potential for out-of-pocket costs associated with LARC, even when covered by insurance. This knowledge can help inform patient counseling and financial planning regarding contraceptive options.
Conclusion
The findings indicate a significant gap between policy mandates and actual patient experiences regarding contraceptive coverage. Addressing these discrepancies is essential for improving access to LARC.
